BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Z, Li X, Wang D, Zou Y, Qu X, He C, Deng Y, Jin Y, Zhou Y, Zhou Y, Liu Y. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles. Acta Biomater 2017;62:144-56. [PMID: 28842335 DOI: 10.1016/j.actbio.2017.08.027] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Chaudhuri A, Ramesh K, Kumar DN, Dehari D, Singh S, Kumar D, Agrawal AK. Polymeric micelles: A novel drug delivery system for the treatment of breast cancer. Journal of Drug Delivery Science and Technology 2022;77:103886. [DOI: 10.1016/j.jddst.2022.103886] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Junnuthula V, Kolimi P, Nyavanandi D, Sampathi S, Vora LK, Dyawanapelly S. Polymeric Micelles for Breast Cancer Therapy: Recent Updates, Clinical Translation and Regulatory Considerations. Pharmaceutics 2022;14:1860. [PMID: 36145608 DOI: 10.3390/pharmaceutics14091860] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lu X, Lu X, Yang P, Zhang Z, Lv H. Honokiol nanosuspensions loaded thermosensitive hydrogels as the local delivery system in combination with systemic paclitaxel for synergistic therapy of breast cancer. European Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.ejps.2022.106212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Khursheed R, Paudel KR, Gulati M, Vishwas S, Jha NK, Hansbro PM, Oliver BG, Dua K, Singh SK. Expanding the arsenal against pulmonary diseases using surface-functionalized polymeric micelles: breakthroughs and bottlenecks. Nanomedicine (Lond) 2022. [PMID: 35332783 DOI: 10.2217/nnm-2021-0451] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
5 Amjad MW. Polymeric micelles for drug codelivery. Polymeric Micelles for Drug Delivery 2022. [DOI: 10.1016/b978-0-323-89868-3.00005-7] [Reference Citation Analysis]
6 De R, Mahata MK, Song YH, Kim K. Nanobody-Based Delivery Systems for Diagnosis and Therapeutic Applications. Nanotechnology in the Life Sciences 2022. [DOI: 10.1007/978-3-031-12658-1_8] [Reference Citation Analysis]
7 Cao L, Zhu Y, Wang W, Wang G, Zhang S, Cheng H. Emerging Nano-Based Strategies Against Drug Resistance in Tumor Chemotherapy. Front Bioeng Biotechnol 2021;9:798882. [DOI: 10.3389/fbioe.2021.798882] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
8 Zhou C, Hu X, Liu Q, Wang L, Zhou Y, Jin Y, Ma Y, Liu Y. Stromal Barrier-Dismantled Nanodrill-Like and Cancer Cell-Targeted pH-Responsive Polymeric Micelles for Further Enhancing the Anticancer Efficacy of Doxorubicin. ACS Biomater Sci Eng 2021. [PMID: 34761919 DOI: 10.1021/acsbiomaterials.1c01131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Zhang J, Hu K, Di L, Wang P, Liu Z, Zhang J, Yue P, Song W, Zhang J, Chen T, Wang Z, Zhang Y, Wang X, Zhan C, Cheng YC, Li X, Li Q, Fan JY, Shen Y, Han JY, Qiao H. Traditional herbal medicine and nanomedicine: Converging disciplines to improve therapeutic efficacy and human health. Adv Drug Deliv Rev 2021;178:113964. [PMID: 34499982 DOI: 10.1016/j.addr.2021.113964] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
10 Gote V, Nookala AR, Bolla PK, Pal D. Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue. Int J Mol Sci 2021;22:4673. [PMID: 33925129 DOI: 10.3390/ijms22094673] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
11 Sezgin-Bayindir Z, Losada-Barreiro S, Bravo-Díaz C, Sova M, Kristl J, Saso L. Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy. Antioxidants (Basel) 2021;10:685. [PMID: 33925605 DOI: 10.3390/antiox10050685] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
12 Ke L, Li Z, Fan X, Loh XJ, Cheng H, Wu YL, Li Z. Cyclodextrin-Based Hybrid Polymeric Complex to Overcome Dual Drug Resistance Mechanisms for Cancer Therapy. Polymers (Basel) 2021;13:1254. [PMID: 33924348 DOI: 10.3390/polym13081254] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
13 Fulfager AD, Yadav KS. Understanding the implications of co-delivering therapeutic agents in a nanocarrier to combat multidrug resistance (MDR) in breast cancer. Journal of Drug Delivery Science and Technology 2021;62:102405. [DOI: 10.1016/j.jddst.2021.102405] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Lan M, Lu W, Zou T, Li L, Liu F, Cai T, Cai Y. Role of inflammatory microenvironment: potential implications for improved breast cancer nano-targeted therapy. Cell Mol Life Sci 2021;78:2105-29. [PMID: 33386887 DOI: 10.1007/s00018-020-03696-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
15 Wang H, Guo S, Kim SJ, Shao F, Ho JWK, Wong KU, Miao Z, Hao D, Zhao M, Xu J, Zeng J, Wong KH, Di L, Wong AH, Xu X, Deng CX. Cisplatin prevents breast cancer metastasis through blocking early EMT and retards cancer growth together with paclitaxel. Theranostics 2021;11:2442-59. [PMID: 33500735 DOI: 10.7150/thno.46460] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
16 Chaturvedi S, Pathak K. Nanoparticulate systems and their translation potential for breast cancer therapeutics. Advanced Drug Delivery Systems in the Management of Cancer 2021. [DOI: 10.1016/b978-0-323-85503-7.00021-3] [Reference Citation Analysis]
17 Alven S, Aderibigbe BA. The Therapeutic Efficacy of Dendrimer and Micelle Formulations for Breast Cancer Treatment. Pharmaceutics 2020;12:E1212. [PMID: 33333778 DOI: 10.3390/pharmaceutics12121212] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
18 Oshiro-Júnior JA, Rodero C, Hanck-Silva G, Sato MR, Alves RC, Eloy JO, Chorilli M. Stimuli-responsive Drug Delivery Nanocarriers in the Treatment of Breast Cancer. Curr Med Chem 2020;27:2494-513. [PMID: 30306849 DOI: 10.2174/0929867325666181009120610] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
19 Kumar M, Jha A, Dr M, Mishra B. Targeted drug nanocrystals for pulmonary delivery: a potential strategy for lung cancer therapy. Expert Opin Drug Deliv 2020;17:1459-72. [PMID: 32684002 DOI: 10.1080/17425247.2020.1798401] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
20 Zhang Q, Wang J, Liu D, Zhu W, Guan S, Fan L, Cai D. Targeted delivery of honokiol by zein/hyaluronic acid core-shell nanoparticles to suppress breast cancer growth and metastasis. Carbohydr Polym 2020;240:116325. [PMID: 32475585 DOI: 10.1016/j.carbpol.2020.116325] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
21 Khonkarn R, Daowtak K, Okonogi S. Chemotherapeutic Efficacy Enhancement in P-gp-Overexpressing Cancer Cells by Flavonoid-Loaded Polymeric Micelles. AAPS PharmSciTech 2020;21:121. [PMID: 32337630 DOI: 10.1208/s12249-020-01657-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
22 Yu C, Wang L, Xu Z, Teng W, Wu Z, Xiong D. Smart micelles self-assembled from four-arm star polymers as potential drug carriers for pH-triggered DOX release. J Polym Res 2020;27. [DOI: 10.1007/s10965-020-02108-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
23 Pourjavadi A, Rahemipoor S, Kohestanian M. Synthesis and characterization of multi stimuli-responsive block copolymer-silica hybrid nanocomposite with core-shell structure via RAFT polymerization. Composites Science and Technology 2020;188:107951. [DOI: 10.1016/j.compscitech.2019.107951] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
24 Wang J, Liu D, Guan S, Zhu W, Fan L, Zhang Q, Cai D. Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer. Carbohydr Polym 2020;235:115981. [PMID: 32122511 DOI: 10.1016/j.carbpol.2020.115981] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
25 Lu X, Lu X, Zhang Z, Lv H. Preparation and Characterization of Honokiol Nanosuspensions and Preliminary Evaluation of Anti-Inflammatory Effect. AAPS PharmSciTech 2020;21:62. [PMID: 31925586 DOI: 10.1208/s12249-019-1602-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
26 Costea T, Vlad OC, Miclea LC, Ganea C, Szöllősi J, Mocanu MM. Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer. Int J Mol Sci 2020;21:E401. [PMID: 31936346 DOI: 10.3390/ijms21020401] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 10.7] [Reference Citation Analysis]
27 Rostamizadeh K, Torchilin VP. Polymeric nanomicelles as versatile tool for multidrug delivery in chemotherapy. Nanopharmaceuticals 2020. [DOI: 10.1016/b978-0-12-817778-5.00003-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Zhou Y, Zhou C, Zou Y, Jin Y, Han S, Liu Q, Hu X, Wang L, Ma Y, Liu Y. Multi pH-sensitive polymer–drug conjugate mixed micelles for efficient co-delivery of doxorubicin and curcumin to synergistically suppress tumor metastasis. Biomater Sci 2020;8:5029-46. [DOI: 10.1039/d0bm00840k] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
29 Ong CP, Lee WL, Tang YQ, Yap WH. Honokiol: A Review of Its Anticancer Potential and Mechanisms. Cancers (Basel) 2019;12:E48. [PMID: 31877856 DOI: 10.3390/cancers12010048] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 16.0] [Reference Citation Analysis]
30 Eftekhari RB, Maghsoudnia N, Samimi S, Zamzami A, Dorkoosh FA. Co-Delivery Nanosystems for Cancer Treatment: A Review. PNT 2019;7:90-112. [DOI: 10.2174/2211738507666190321112237] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
31 Yu G, Ning Q, Mo Z, Tang S. Intelligent polymeric micelles for multidrug co-delivery and cancer therapy. Artificial Cells, Nanomedicine, and Biotechnology 2019;47:1476-87. [DOI: 10.1080/21691401.2019.1601104] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 10.8] [Reference Citation Analysis]
32 Field LD, Nag OK, Sangtani A, Burns KE, Delehanty JB. The role of nanoparticles in the improvement of systemic anticancer drug delivery. Ther Deliv 2018;9:527-45. [PMID: 29943689 DOI: 10.4155/tde-2018-0015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
33 Su F, Yun P, Li C, Li R, Xi L, Wang Y, Chen Y, Li S. Novel self-assembled micelles of amphiphilic poly(2-ethyl-2-oxazoline) -poly(L-lactide) diblock copolymers for sustained drug delivery. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2019;566:120-7. [DOI: 10.1016/j.colsurfa.2019.01.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
34 Yu R, Zou Y, Liu B, Guo Y, Wang X, Han M. Surface modification of pH-sensitive honokiol nanoparticles based on dopamine coating for targeted therapy of breast cancer. Colloids Surf B Biointerfaces 2019;177:1-10. [PMID: 30690424 DOI: 10.1016/j.colsurfb.2019.01.047] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
35 Du B, Ding X, Wang H, Du Q, Xu T, Huang J, Zhou J, Cheng G. Development of an interactive tumor vascular suppression strategy to inhibit multidrug resistance and metastasis with pH/H 2 O 2 responsive and oxygen-producing nanohybrids. J Mater Chem B 2019;7:4784-93. [DOI: 10.1039/c9tb00546c] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
36 Jin Y, Liu Q, Zhou C, Hu X, Wang L, Han S, Zhou Y, Liu Y. Intestinal oligopeptide transporter PepT1-targeted polymeric micelles for further enhancing the oral absorption of water-insoluble agents. Nanoscale 2019;11:21433-48. [DOI: 10.1039/c9nr07029j] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
37 Rauf A, Patel S, Imran M, Maalik A, Arshad MU, Saeed F, Mabkhot YN, Al-showiman SS, Ahmad N, Elsharkawy E. Honokiol: An anticancer lignan. Biomedicine & Pharmacotherapy 2018;107:555-62. [DOI: 10.1016/j.biopha.2018.08.054] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 8.6] [Reference Citation Analysis]
38 Lorson T, Lübtow MM, Wegener E, Haider MS, Borova S, Nahm D, Jordan R, Sokolski-papkov M, Kabanov AV, Luxenhofer R. Poly(2-oxazoline)s based biomaterials: A comprehensive and critical update. Biomaterials 2018;178:204-80. [DOI: 10.1016/j.biomaterials.2018.05.022] [Cited by in Crossref: 200] [Cited by in F6Publishing: 204] [Article Influence: 40.0] [Reference Citation Analysis]
39 Huang X, Liao W, Xie Z, Chen D, Zhang CY. A pH-responsive prodrug delivery system self-assembled from acid-labile doxorubicin-conjugated amphiphilic pH-sensitive block copolymers. Materials Science and Engineering: C 2018;90:27-37. [DOI: 10.1016/j.msec.2018.04.036] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
40 Gou Y, Zhang Z, Li D, Zhao L, Cai M, Sun Z, Li Y, Zhang Y, Khan H, Sun H, Wang T, Liang H, Yang F. HSA-based multi-target combination therapy: regulating drugs' release from HSA and overcoming single drug resistance in a breast cancer model. Drug Deliv 2018;25:321-9. [PMID: 29350051 DOI: 10.1080/10717544.2018.1428245] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
41 Zou Y, Zhou Y, Jin Y, He C, Deng Y, Han S, Zhou C, Li X, Zhou Y, Liu Y. Synergistically Enhanced Antimetastasis Effects by Honokiol-Loaded pH-Sensitive Polymer-Doxorubicin Conjugate Micelles. ACS Appl Mater Interfaces 2018;10:18585-600. [PMID: 29749228 DOI: 10.1021/acsami.8b04854] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]